Market Capitalization (Millions $) |
0 |
Shares
Outstanding (Millions) |
168 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-3 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Respirerx Pharmaceuticals Inc
Respirerx Pharmaceuticals Inc is a pharmaceutical company that specializes in the development and commercialization of respiratory and CNS therapeutics. The company focuses on the treatment of diseases such as chronic obstructive pulmonary disease (COPD) and asthma. Respirerx Pharmaceuticals aims to provide innovative and effective therapies that improve the lives of patients suffering from these conditions.
Company Address: 126 Valley Road Glen Rock 7452 NJ
Company Phone Number: 444-4947 Stock Exchange / Ticker: RSPI
RSPI is expected to report next financial results on April 16, 2024. |
|
|